Paper42414740
Development and validation of a radiomics nomogram for predicting outcomes following combined radiotherapy and modern chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: a multicenter study.
Gong J and 18 others. Ann Hematol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Development and validation of a radiomics nomogram for predicting outcomes following combined radiotherapy and modern chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: a multicenter study. Papers, record 42414740. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42414740
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Development and validation of a radiomics nomogram for predicting outcomes following combined radiotherapy and modern chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: a multicenter study.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chemoradiotherapy | Major topic |
| Lymphoma, Extranodal NK-T-Cell | Major topic |
| Nomograms | Major topic |
| Radiomics | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Young Adult | |
| Antineoplastic Combined Chemotherapy Protocols | |
| Neoplasm Staging | |
| Prognosis | |
| Treatment Outcome |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| XJZT24QN04 | Xijing Hospital Research Project | PubMed | ||
| 2023LC2316 | Air Force Medical University Research Project | PubMed |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36805888 | Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management. | Semin Hematol | 2022 | https://conductscience.org/library/papers/36805888 | PubMed |
| 2 | 36819187 | Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database. | EJHaem | 2023 | https://conductscience.org/library/papers/36819187 | PubMed |
| 3 | 18676879 | Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring. | Blood | 2008 | https://conductscience.org/library/papers/18676879 | PubMed |
| 4 | 24495590 | Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma. | Int J Radiat Oncol Biol Phys | 2014 | https://conductscience.org/library/papers/24495590 | PubMed |
| 5 | 32844695 | Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population. | Leuk Lymphoma | 2020 | https://conductscience.org/library/papers/32844695 | PubMed |
| 6 | 26726970 | Sequential DICE combined with l-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma. | Leuk Lymphoma | 2016 | https://conductscience.org/library/papers/26726970 | PubMed |
| 7 | 22811078 | First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma. | Cancer | 2013 | https://conductscience.org/library/papers/22811078 | PubMed |
| 8 | 25409913 | Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with L-asparaginase-containing chemotherapy--a single institution experience. | Ann Hematol | 2015 | https://conductscience.org/library/papers/25409913 | PubMed |
| 9 | 32449800 | Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study. | Am J Hematol | 2020 | https://conductscience.org/library/papers/32449800 | PubMed |
| 10 | 26109206 | Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study. | Blood | 2015 | https://conductscience.org/library/papers/26109206 | PubMed |
| 11 | 32152465 | Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making. | Leukemia | 2021 | https://conductscience.org/library/papers/32152465 | PubMed |
| 12 | 32943751 | Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study. | Leukemia | 2021 | https://conductscience.org/library/papers/32943751 | PubMed |
| 13 | 12933580 | Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. | Blood | 2004 | https://conductscience.org/library/papers/12933580 | PubMed |
| 14 | 26873565 | A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. | Lancet Oncol | 2016 | https://conductscience.org/library/papers/26873565 | PubMed |
| 15 | 32435928 | Development and validation of an 18F-FDG PET radiomic model for prognosis prediction in patients with nasal-type extranodal natural killer/T cell lymphoma. | Eur Radiol | 2020 | https://conductscience.org/library/papers/32435928 | PubMed |
| 16 | 38288898 | Prognostic Value of 18F-FDG PET/CT Radiomics in Extranodal Nasal-Type NK/T Cell Lymphoma. | Korean J Radiol | 2024 | https://conductscience.org/library/papers/38288898 | PubMed |
| 17 | 29092951 | Computational Radiomics System to Decode the Radiographic Phenotype. | Cancer Res | 2017 | https://conductscience.org/library/papers/29092951 | PubMed |
| 18 | 25697894 | Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study. | Leukemia | 2015 | https://conductscience.org/library/papers/25697894 | PubMed |
| 19 | 36570690 | The Novel Prognostic Index Model of Combining Circulating Tumor DNA and PINK-E Predicts the Clinical Outcomes for Newly Diagnosed Extranodal NK/T-cell Lymphoma. | Hemasphere | 2023 | https://conductscience.org/library/papers/36570690 | PubMed |
| 20 | 35726449 | A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort. | Am J Hematol | 2022 | https://conductscience.org/library/papers/35726449 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42414740
GET https://conductscience.org/api/papers/v1/42414740/references?page=2